Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

2 Jul 2008 16:26

RNS Number : 1804Y
Chamberlin PLC
02 July 2008
 



CHAMBERLIN PLC (THE "COMPANY")

Directors' Dealings

The Company announces that on 2 July 2008, awards over ordinary shares with a nominal value of 25 pence each in the Company ("Shares") were made under the rules of the Chamberlin & Hill Performance Share Plan and the Chamberlin & Hill Share Option Plan to Directors of the Company, as follows:

Chamberlin & Hill Performance Share Plan ("PSP")

Director

Number of EMI options over Shares awarded 

Number of unapproved options over Shares awarded 

Total revised number of Shares over which options are held under the PSP

Tim Hair

11,940

14,925

76,860

Mark Bache

17,910

0

56,367

Adam Vickery

13,432

0

47,275

Under the PSP, awards are structured as nil-cost options granted under the Enterprise Management Incentives Scheme ("EMI") contained in Schedule 5 to the Income Tax (Earnings and Pensions) Act 2003. To the extent that an award is granted under the Plan in excess of the EMI individual limit of £120,000, the excess is treated as an Unapproved Option which is subject to the same terms as the EMI Option.

No consideration was paid for the grant of the Options.

The vesting of an Option is subject to the continued employment of the participant and the satisfaction of a performance condition set by the Remuneration Committee of the Company. The Option will normally become exercisable on the third anniversary of the date of grant subject to the satisfaction of a performance condition set by the Remuneration Committee of the Company.

To the extent that an EMI Option or any part of an EMI Option becomes exercisable, it remains exercisable until the tenth anniversary of the date of grant. To the extent that an Unapproved Option or any part of an Unapproved Option becomes exercisable, it remains exercisable for a period of 12 months from the date of vesting.

Chamberlin & Hill Share Option Plan ("SOP")

Director

Number of options over Shares awarded 

Total revised number of Shares over which options are held under the SOP

Tim Hair

303,680

505,962

Mark Bache

147,237

250,971

No consideration was paid for the grant of options under the SOP, which are structured as market value options.

The options will normally become exercisable in three equal tranches on each of the third, fourth and fifth anniversaries of the date of grant subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. To the extent that an option or any part of an option becomes exercisable, it remains exercisable until the tenth anniversary of the date of grant.

The option price payable by each participant on the exercise of his option is 163p.

The Company was informed of the above transactions under the PSP and SOP on 2 July 2008.

Enquiries:

Chamberlin plc

Tom Brown, Chairman 01922 707100

Tim Hair, Chief Executive  01922 707100

Landsbanki Securities (UK) Limited

Tom Hulme, NOMAD 020 7426 9000

Citigate Dewe Rogerson

Toby Mountford 07710 356611

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSIFIESASEEW
Date   Source Headline
9th May 20186:05 pmRNSHolding(s) in Company
9th May 20184:30 pmRNSHolding(s) in Company
9th May 20184:30 pmRNSHolding(s) in Company
12th Apr 20187:00 amRNSTrading Update
26th Mar 20187:00 amRNSBoard Appointment
22nd Jan 20187:00 amRNSMachining claim update
6th Dec 20177:00 amRNSDirectors' Interests
1st Dec 20177:00 amRNSBoard Change
28th Nov 20177:00 amRNSHalf-year Results
18th Oct 20177:00 amRNSTrading Update
20th Jul 201711:48 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
5th Jun 20177:00 amRNSHolding(s) in Company
23rd May 20177:00 amRNSFinal Results
11th Apr 20177:00 amRNSTrading Update
23rd Mar 20177:00 amRNSNew Machining Facility Open Day
21st Mar 20172:24 pmRNSHardman Research: Turbo-charging into growth phase
10th Jan 20172:15 pmRNSAppointment of new Nominated Adviser and Broker
19th Dec 20165:01 pmRNSDirector/PDMR Shareholding
29th Nov 20167:00 amRNSHalf-year Report
21st Nov 20167:00 amRNSTrading update
27th Sep 20161:50 pmRNSHolding(s) in Company
8th Aug 201612:43 pmRNSHolding(s) in Company
22nd Jul 20162:24 pmRNSResult of AGM
22nd Jul 20167:00 amRNSAGM Statement
18th Jul 20167:00 amRNSBoard Appointment
29th Jun 20167:00 amRNSPromoted to Category "A" supplier by IHI
24th May 20167:00 amRNSFinal Results
29th Feb 20167:00 amRNSTrading Update, New Contract & New Facility
26th Jan 20164:26 pmRNSHolding(s) in Company
26th Jan 20161:19 pmRNSHolding(s) in Company
5th Jan 20161:26 pmRNSHolding(s) in Company
1st Dec 201510:03 amRNSDirector/PDMR Shareholding
24th Nov 20157:00 amRNSHalf Yearly Report
6th Aug 20157:00 amRNSChange of Adviser
4th Aug 20153:58 pmRNSHolding(s) in Company
17th Jul 20155:07 pmRNSResult of AGM
17th Jul 20157:00 amRNSAGM Statement
19th May 20157:00 amRNSFinal Results
27th Nov 20144:50 pmRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSHalf Yearly Results
18th Nov 20147:00 amRNSMajor Contract Win
17th Oct 20147:00 amRNSMajor contract win
14th Oct 20147:00 amRNSChange of Auditor
8th Aug 20143:21 pmRNSDirector/PDMR Shareholding
1st Aug 20149:00 amRNSResult of AGM
31st Jul 20147:00 amRNSAGM Statement
20th May 20147:00 amRNSFinal Results
26th Nov 20137:00 amRNSHalf Yearly Results
31st Oct 201312:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.